Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients
Reubi-Kattenbusch, J.-C., Waser, B., Cescato, R., Gloor, B., Stettler, C., & Christ, E. (2010). Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients. Journal of Clinical Endocrinology and Metabolism, 95(5), 2343–2350. https://doi.org/10.1210/jc.2009-2487
DOI
Publisher DOI
PubMed ID
20228164
Abstract
Somatostatin receptor subtype 2 (sst(2)) is widely expressed in neuroendocrine tumors and can be visualized immunohistochemically at the cell membrane for diagnostic purposes. Recently, it has been demonstrated in animal sst(2) tumor models in vivo that somatostatin analog treatment was able to induce a complete internalization of the tumor sst(2).
Date Issued
2010
Publication Type
Article
Language(s)
en
Author(s)
Journal
Journal of clinical endocrinology and metabolism
Publisher
Endocrine Society
ISSN
0021-972X
Access(Rights)
restricted